Denali Therapeutics Inc.

NASDAQ:DNLI

Biotechnology

Healthcare
$18.20 +0.40%

+$0.09 today

Market cap
$2.92B
Beta
1.01
P/E (TTM)
-8.7
EPS (TTM)
-$2.72
52W Low $12.58High $24.65

Volume 1.27M

Average 1.84M

Private 5-step workspace

Build a DNLI investment thesis

Turn Denali Therapeutics Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.

Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.